Finzati - Logo
AKBA logo

Akebia Therapeutics, Inc.

AKBA • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$258.04M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive free cash flow · 0.26High debt level · 6.63Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:30 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$258.04M
52W Range0.82 - 3.44
Beta0.24
Gross Margin83.29%
Oper. Margin9.95%
Profit Margin-2.26%
Debt/Eq6.63
Current Ratio1.13
Quick Ratio1.04
Target$1.00

Investment DNA

How strong this company looks for long-term investors

38
out of 100
Business Quality
Margins, moat, returns
30/100
Financial Strength
Debt, cash, stability
41/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
63/100
Why this score▼
Positive free cash flow · 0.26High debt level · 6.63Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$1.00
Mean
$1.00
Median
$1.00
High
$1.00

Company Overview

IPO: 3/20/2014
Industry: Biotechnology
P/B i: 12.70
Debt / Equity i: 6.63
Operating Margin: 9.95%
Net Margin: -2.26%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 6.63
Current Ratio: 1.13
Quick Ratio: 1.04
Status: Moderate

Warnings

  • High debt level

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Ostrowski Erik
Transaction: 06/29/2026
SELL
Change
-56,019
Price
$1.11
Filing
07/01/2026
Type
SELL
ADAMS ADRIAN
Transaction: 06/17/2026
BUY
Change
+53,600
Price
$1.02
Filing
06/22/2026
Type
BUY
ADAMS ADRIAN
Transaction: 06/17/2026
BUY
Change
+35,700
Price
Not reported
Filing
06/22/2026
Type
BUY